Cargando…

Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockade

BACKGROUND: Newcastle disease virus (NDV) has shown noticeable oncolytic properties, especially against cervical cancer. However, in order to improve the spread rate and oncotoxicity of the virus, employment of other therapeutic reagents would be helpful. It has been shown that some viral fusogenic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miri, Seyed Mohammad, Ebrahimzadeh, Mir Saeed, Abdolalipour, Elahe, Yazdi, Mahsa, Hosseini Ravandi, Hassan, Ghaemi, Amir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412675/ https://www.ncbi.nlm.nih.gov/pubmed/32782438 http://dx.doi.org/10.1186/s12935-020-01476-5

Ejemplares similares

Correction to: Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockade
por: Miri, Seyed Mohammad, et al.
Publicado: (2020)

Fusogenic Viruses in Oncolytic Immunotherapy
por: Krabbe, Teresa, et al.
Publicado: (2018)

Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment
por: Keshavarz, Mohsen, et al.
Publicado: (2020)

Correction to: Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment
por: Keshavarz, Mohsen, et al.
Publicado: (2020)

The immunomodulatory effects of probiotics on respiratory viral infections: A hint for COVID-19 treatment?
por: Mahooti, Mehran, et al.
Publicado: (2020)

Hexokinase inhibition using D-Mannoheptulose enhances oncolytic newcastle disease virus-mediated killing of breast cancer cells
por: Al-Ziaydi, Ahmed Ghdhban, et al.
Publicado: (2020)

Anti-Tumor Effects of an Oncolytic Adenovirus Expressing Hemagglutinin-Neuraminidase of Newcastle Disease Virus in Vitro and in Vivo
por: He, Dongyun, et al.
Publicado: (2014)

Oncolytic Newcastle disease virus reduces growth of cervical cancer cell by inducing apoptosis
por: Keshavarz, Mohsen, et al.
Publicado: (2020)

Bovine Lactoferrin Prevents Influenza A Virus Infection by Interfering with the Fusogenic Function of Viral Hemagglutinin
por: Superti, Fabiana, et al.
Publicado: (2019)

A novel fusogenic herpes simplex virus for oncolytic virotherapy of squamous cell carcinoma
por: Takaoka, Hiroo, et al.
Publicado: (2011)

Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity
por: Ghaemi, Amir, et al.
Publicado: (2022)

Influenza Virus-Mediated Membrane Fusion: Determinants of Hemagglutinin Fusogenic Activity and Experimental Approaches for Assessing Virus Fusion
por: Hamilton, Brian S., et al.
Publicado: (2012)

Adoptive T Cell Therapy Is Complemented by Oncolytic Virotherapy with Fusogenic VSV-NDV in Combination Treatment of Murine Melanoma
por: Krabbe, Teresa, et al.
Publicado: (2021)

Cell-line screening and process development for a fusogenic oncolytic virus in small-scale suspension cultures
por: Göbel, Sven, et al.
Publicado: (2022)

Comprehensive analysis of amino acid sequence diversity at the F protein cleavage site of Newcastle disease virus in fusogenic activity
por: Wang, Yanhong, et al.
Publicado: (2017)

Oncolytic paramyxoviruses-induced autophagy; a prudent weapon for cancer therapy
por: Keshavarz, Mohsen, et al.
Publicado: (2019)

Treatment of human hepatocellular carcinoma by the oncolytic herpes simplex virus G47delta
por: Wang, Jiani, et al.
Publicado: (2014)

Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer
por: Simpson, G R, et al.
Publicado: (2012)

Correction to: Oncolytic paramyxoviruses-induced autophagy; a prudent weapon for cancer therapy
por: Keshavarz, Mohsen, et al.
Publicado: (2019)

Newcastle Disease Virus Hemagglutinin Neuraminidase as a Potential Cancer Targeting Agent
por: Baradaran, Ali, et al.
Publicado: (2016)

Reduced Newcastle disease virus-induced oncolysis in a subpopulation of cisplatin-resistant MCF7 cells is associated with survivin stabilization
por: Jamal, Mohd-Hafifi, et al.
Publicado: (2012)

Emodin regulates cell cycle of non-small lung cancer (NSCLC) cells through hyaluronan synthase 2 (HA2)-HA-CD44/receptor for hyaluronic acid-mediated motility (RHAMM) interaction-dependent signaling pathway
por: Li, Mingzhu, et al.
Publicado: (2021)

Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host
por: Fournier, Philippe, et al.
Publicado: (2013)

Therapeutic potential of oncolytic Newcastle disease virus: a critical review
por: Tayeb, Shay, et al.
Publicado: (2015)

The Viral Knock: Ameliorating Cancer Treatment with Oncolytic Newcastle Disease Virus
por: Pathak, Upasana, et al.
Publicado: (2023)

Structural basis of malaria transmission blockade by a monoclonal antibody to gamete fusogen HAP2
por: Feng, Juan, et al.
Publicado: (2021)

Influence of Membrane–Fusogen Distance on the Secondary Structure of Fusogenic Coiled Coil Peptides
por: Daudey, Geert A., et al.
Publicado: (2019)

Lonidamine potentiates the oncolytic efficiency of M1 virus independent of hexokinase 2 but via inhibition of antiviral immunity
por: Cai, Jing, et al.
Publicado: (2020)

Cell type-specific response of colon cancer tumor cell lines to oncolytic HSV-1 virotherapy in hypoxia
por: Shayan, Sara, et al.
Publicado: (2022)

Identification of a potential neutralizing linear epitope of hemagglutinin-neuraminidase in Newcastle disease virus
por: Jin, Zhongyuan, et al.
Publicado: (2021)

Hemagglutinin-neuraminidase gene of genotype VII Newcastle disease virus strains isolated in Japan
por: MASE, Masaji
Publicado: (2021)

In silico prioritization and further functional characterization of SPINK1 intronic variants
por: Zou, Wen-Bin, et al.
Publicado: (2017)

CELL BLOCKADE IN NEWCASTLE DISEASE OF CHICKENS AND CHICKEN EMBRYOS
por: Bang, F. B.
Publicado: (1949)

Two mutations in the HR2 region of Newcastle disease virus fusion protein with a cleavage motif “RRQRRL” are critical for fusogenic activity
por: Wang, Yanhong, et al.
Publicado: (2017)

Cellular CARD11 Inhibits the Fusogenic Activity of Newcastle Disease Virus via CBM Signalosome-Mediated Furin Reduction in Chicken Fibroblasts
por: Wang, Wenbin, et al.
Publicado: (2021)

Multi-tyrosine kinase inhibitors in preclinical studies for pediatric CNS AT/RT: Evidence for synergy with Topoisomerase-I inhibition
por: Jayanthan, Aarthi, et al.
Publicado: (2011)

Carboxypeptidase N1 is anticipated to be a synergy metrics for chemotherapy effectiveness and prognostic significance in invasive breast cancer
por: Cui, Ranliang, et al.
Publicado: (2021)

Adaptation of the Newcastle Disease Virus to Cell Cultures for Enhancing Its Oncolytic Properties
por: Yurchenko, K. S., et al.
Publicado: (2019)

Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy
por: Huang, Fang, et al.
Publicado: (2022)

Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy
por: Schirrmacher, Volker, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_opllmov51q3gt71iive7s56fvo